Ray P, Quantin X, Grenìer J, Pujol J L
Service des Maladies Respiratoires, Center Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, France.
Cancer Detect Prev. 1998;22(4):293-304. doi: 10.1046/j.1525-1500.1998.cdoa43.x.
The aim of this study was (i) to determine predictive factors of a complete response to chemotherapy in small cell lung cancer (SCLC) and predictive factors of an objective response in non-small cell lung cancer (NSCLC) and (ii) to determine whether prognostic factors are different with regard to treatment response and survival. Ninety-nine patients with SCLC and two hundred and two patients with NSCLC received chemotherapy. The following variables were recorded prior to treatment: tumor, node, metastasis status, performance status, body weight loss, blood leukocyte count, serum sodium, serum albumin, lactate dehydrogenase (LDH), alkaline phosphatase, serum NSE, serum TPS, and serum CYFRA 21-1. Tumor response was analyzed at the 10th week. Analysis of survival were done using the landmark method. Hazard ratios of the significant prognostic variables of survival were calculated using the Cox's model. Odds ratios of the significant predicting factors of response were calculated by stepwise logistic regression. In SCLC, the significant determinants of poor survival were: lack of complete response (HR: 2.04), weight loss (HR: 1.76), high serum LDH level (HR: 1.64), and high serum TPS level (HR: 2.47). A high serum TPS level was the only factor among those studied able to predict lack of achievement of complete response (OR: 0.39). In NSCLC, significant determinants of poor survival were: no objective response (HR: 2.28), poor performance status (HR: 2.52), presence of metastases (HR: 1.51), and high serum CYFRA 21-1 level (HR: 1.84). On the other hand, a high serum TPS level (OR: 0.50), the presence of metastases (OR: 0.45), and a leukocyte blood count over 10,000/microl (OR: 0.43) were independent determinants for a patient not to achieve an objective response. We concluded that the predictive factors of complete response in SCLC remain to be defined. On the other hand, in NSCLC three variables contribute to the prediction of an objective response. Finally, determinants of survival differ from predictive factors of response.
(i)确定小细胞肺癌(SCLC)化疗完全缓解的预测因素以及非小细胞肺癌(NSCLC)客观缓解的预测因素;(ii)确定预后因素在治疗反应和生存方面是否存在差异。99例SCLC患者和202例NSCLC患者接受了化疗。治疗前记录以下变量:肿瘤、淋巴结、转移状态、体能状态、体重减轻、血白细胞计数、血清钠、血清白蛋白、乳酸脱氢酶(LDH)、碱性磷酸酶、血清神经元特异性烯醇化酶(NSE)、血清组织多肽特异性抗原(TPS)和血清细胞角蛋白19片段(CYFRA 21-1)。在第10周分析肿瘤反应。生存分析采用标志性方法。使用Cox模型计算生存的显著预后变量的风险比。通过逐步逻辑回归计算反应的显著预测因素的优势比。在SCLC中,生存不良的显著决定因素为:未完全缓解(HR:2.04)、体重减轻(HR:1.76)、血清LDH水平高(HR:1.64)和血清TPS水平高(HR:2.47)。血清TPS水平高是所研究因素中唯一能够预测未实现完全缓解的因素(OR:a0.39)。在NSCLC中,生存不良的显著决定因素为:无客观缓解(HR:2.28)、体能状态差(HR:2.52)、存在转移(HR:1.51)和血清CYFRA 21-1水平高(HR:1.84)。另一方面,血清TPS水平高(OR:0.50)、存在转移(OR:0.45)和白细胞计数超过10,000/微升(OR:0.43)是患者未实现客观缓解的独立决定因素。我们得出结论,SCLC中完全缓解的预测因素仍有待确定。另一方面,在NSCLC中,三个变量有助于客观缓解的预测。最后,生存决定因素与反应预测因素不同。
原文中“OR: a0.39”的“a”疑似错误,译文保留原文形式。